Literature DB >> 34774246

Hypercalcemia in Pregnancy.

Karel Dandurand1, Dalal S Ali1, Aliya A Khan2.   

Abstract

Hypercalcemic disorders are rare in pregnant women and are usually due to primary hyperparathyroidism. Clinical manifestations of hypercalcemia are nonspecific and can be masked by the physiologic changes of pregnancy. Furthermore, routine antenatal screening does not include serum calcium measurement and a hypercalcemia diagnosis may therefore be delayed until term or even after delivery. Timely recognition and appropriate interventions are essential to decrease maternal and fetal complications. Conservative measures are appropriate in the presence of mild hypercalcemia. Parathyroidectomy remains the mainstay of treatment for primary hyperparathyroidism with significant hypercalcemia not responding to conservative measures.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Calcitonin; Cinacalcet; Hypercalcemia; Management; Parathyroidectomy; Pregnancy; Primary hyperparathyroidism

Mesh:

Substances:

Year:  2021        PMID: 34774246     DOI: 10.1016/j.ecl.2021.07.009

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  1 in total

Review 1.  Hypercalcemia in Pregnancy Due to CYP24A1 Mutations: Case Report and Review of the Literature.

Authors:  Stefan Pilz; Verena Theiler-Schwetz; Pawel Pludowski; Sieglinde Zelzer; Andreas Meinitzer; Spyridon N Karras; Waldemar Misiorowski; Armin Zittermann; Winfried März; Christian Trummer
Journal:  Nutrients       Date:  2022-06-17       Impact factor: 6.706

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.